drugset / Trial / NCT01447069

Use of Beta-agonists in Stable Severe Congestive Heart Failure

NCT01447069

Unknown 30 enrolled Rabin Medical Center
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether Salbutamol is effective in the treatment of severe heart failure due to ischemic and non- ischemic cardiomyopathy.

Timeline

Start
2011-10
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Salbutamol Unknown 2 mg